NASDAQ · COCH
Envoy Medical, Inc.
$6.50-$0.16 (-2.4%)
Envoy Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 31.87% below the high.
Loading market information…
NASDAQ · HCTI · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Healthcare Triangle, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.82% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Healthcare Triangle, Inc.’s next earnings report is currently expected on Nov 12, 2026, with estimated earnings per share of -$19.40. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Healthcare Triangle, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Healthcare Triangle, Inc. (HCTI) is a technology firm dedicated to the healthcare sector, specializing in crafting innovative solutions across cloud services, data science, and professional and managed IT support. The company provides a comprehensive array of software, platforms, and services designed to empower healthcare and pharmaceutical organizations. These offerings help facilitate personalized treatment plans, accelerate precision medicine initiatives, drive innovation in drug discovery and development, foster collaborative research efforts, enable evidence-based decision-making, and streamline digital transformation. Among its proprietary software offerings are CloudEz, an enterprise platform streamlining multi-cloud migration and oversight, allowing clients to unify management of their private, hybrid, and public cloud environments. Another key platform is DataEz, a cloud-native solution providing robust data analytics and scientific data processing capabilities tailored for the life sciences, pharmaceutical, and healthcare provider sectors. Additionally, the company offers Readabl.AI, a Software-as-a-Service (SaaS) solution leveraging public cloud-based artificial intelligence and machine learning to intelligently identify and extract vital healthcare data from diverse documents such as faxes and narrative reports. Beyond its platforms, Healthcare Triangle delivers a range of cloud-centric IT services and specialized healthcare IT support. This includes the implementation, optimization, and integration of electronic health records (EHR) systems with community partners, comprehensive application managed services, and reliable public cloud-based backup and disaster recovery solutions. Its diverse client base spans healthcare providers, insurance carriers, pharmaceutical and life sciences firms, biotechnology companies, and medical device manufacturers. Established in 2019, Healthcare Triangle, Inc. operates out of Pleasanton, California, as a subsidiary of SecureKloud Technologies, Inc.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 20, 2025 | -$2,544.91+97.16% vs estimate | $3.70M-72.76% vs estimate |
|---|
| Q4 2024 | Mar 31, 2025 | -$3,443.11+97.12% vs estimate | $2.19M-83.02% vs estimate |
|---|
| Q3 2024 | Nov 14, 2024 | -$3,293.41+97.24% vs estimate | $2.41M-80.54% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$6.50-$0.16 (-2.4%)
Envoy Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 31.87% below the high.
$6.75-$0.44 (-6.12%)
Athira Pharma, Inc.’s quoted price sits in the upper half of its reported 52-week range, 19.26% below the high.
$8.72-$0.03 (-0.29%)
Moleculin Biotech, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.23% below the high.
$2.31-$0.17 (-6.85%)
SeaStar Medical Holding Corporation’s quoted price sits in the lower half of its reported 52-week range, 61.5% below the high.
$0.25-$0.00 (-1.47%)
Mangoceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 89.45% below the high.
$0.73-$0.08 (-10.09%)
Ainos, Inc.’s quoted price sits in the lower half of its reported 52-week range, 81.21% below the high.
$0.09-$0.02 (-18.94%)
Adagio Medical Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.91% below the high.
$1.92$0.00 (0.0%)
VSee Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.11% below the high.
